Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America

Nenhuma Miniatura disponível
Data
2014-05-01
Autores
Condino-Neto, A.
Costa-Carvalho, B. T. [UNIFESP]
Grumach, A. S.
King, A.
Bezrodnik, L.
Oteastro, M.
Leiva, L.
Porras, O.
Espinosa-Rosales, F. J.
Franco, J. L.
Orientadores
Tipo
Artigo
Título da Revista
ISSN da Revista
Título de Volume
Resumo
Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. in this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects. (C) 2012 SEICAP Published by Elsevier Espana, S.L. All rights reserved.
Descrição
Citação
Allergologia Et Immunopathologia. Barcelona: Elsevier Doyma Sl, v. 42, n. 3, p. 245-260, 2014.
Coleções